Navigation Links
Tolera Therapeutics Files IND Application for TOL101, Appoints O'Toole to Lead Clinical Operations
Date:11/3/2009

KALAMAZOO, Mich., Nov. 3 /PRNewswire/ -- Tolera Therapeutics, Inc., announced it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) for its lead candidate, TOL101, for prophylaxis of acute rejection of solid organ transplantation. TOL101 is a novel biologic protein that is designed to safely and specifically target T cells, components of the immune system that play a key role in the rejection, and ultimate failure, of transplanted organs. Organ transplantation is often the only viable treatment for many end-stage organ diseases.

"We are extremely pleased with our progress toward bringing TOL101 to the clinic," commented John J. Puisis, President and CEO of Tolera. "This action marks an important development milestone as the company continues its drive to address the patient's need for safer and more effective immune suppression therapy. Current industry practices and pipelines offer limited and incomplete solutions to advance patient care and meet this critical need. Pending acceptance by the FDA, we intend to conduct clinical studies starting in 2010."

Tolera also announced the appointment of Leslie O'Toole to lead its clinical operations as Director, Clinical Programs. O'Toole brings over 20 years of industry experience with 16 years focusing on clinical research management. Mr. Puisis added "We're excited about adding Leslie to our dynamic team. Her depth of clinical research experience adds an important operating aspect to the organization and positions us for continued success." Prior to joining the company, O'Toole was Director, Project Management at Clinimetrics, a full service contract research organization where she was involved in over 35 studies researching drugs in numerous indications with a primary focus in oncology and immunology.

About Tolera Therapeutics: Tolera Therapeutics is a Kalamazoo, Michigan based biotechnology company and
'/>"/>

SOURCE Tolera Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
3. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
4. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
5. Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on Zero Tolerance for Hepatitis B
6. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
7. Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
8. Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411
9. Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia
10. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
11. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... ,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstC...icalcompanyfocusedondevelopingandcommercializingno...nyDiTonno,PresidentandChiefExecutiveOfficer,issche...eConference,tobeheldDecember1-2,2009atTheNewYorkPa...phenGhiglieri,ChiefFinancialOfficer,willbeavailabl...
(Date:11/24/2009)... , ,Primaryefficacyendpointhasbeenmetforpati...r, , QUEBECCITY,Nov.24/PRNewswire-FirstCall/-...pany"),aglobalbiopharmaceuticalcompanyfocusedonend...icacydatafromaPhase2studywithitstargetedcytotoxicp...swithadvancedorrecurrentendometrialcancer.Inaperso...
(Date:11/24/2009)... ,, REDWOODCITY,Calif.,Nov.24/PRNewswire-Fir...ouncedthatRandyScott,GenomicHealth,sExecutiveChair...reConferenceinNewYorkCityonTuesday,December1,2009a...archivedwebcastofthepresentation,visittheInvestorR...nvestor.genomichealth.com .Pleaseconnecttothewebsi...
(Date:11/24/2009)... ,, SEATTLE,Nov.24/PRNewswire-FirstCall/--Ce...entwillpresentatthe21stAnnualPiperJaffrayHealthCar...9,attheNewYorkPalaceHotel. ,, CTIwillpresentonT...hFloor).AliveaudiowebcastofCTI,spresentationwillbe...obeavailableforreplayafterwards. , ,PiperJaffrayH...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
... jobless recovery, after all. Perhaps its just a m...abor Department figures for March showed the addit...e what it takes (150,000 jobs) in an average month...as the seventh straight month the economy has adde...expanded well beyond the break even point. , ,Stil...
...ntinues to attract readers who do not live in Wisc... resides in Denver, Colorado where she has been a ...nal skill development for public and private busi...l Electric, Inc. Walston has offered to share her ...nd respected speaker, trainer and Courage CoachTM....
...cs are often broken down into categories by race. ... is a meaningless concept that has no basis in bio...ientists and ethicists at a symposium titled Race,...17. The University of Wisconsin-Madisons Holtz Ce... the symposium. , , Marcus Feldman , professor of...
Other Biology Technology:In our changing economy, just-in-time employment masks job creation numbers 2In our changing economy, just-in-time employment masks job creation numbers 3Courage and time 2Symposium examines the effect of race on genetics and disease 2
(Date:11/25/2009)...fornia Institute of Technology (Caltech) have unco...r in the fruit fly, Drosophila melanogaster . , ...tionship between the neurotransmitter dopamine and...are described in the December issue of the journal...y about 20,000 neurons and has long been considere...
(Date:11/25/2009)...s the linchpin of the environment, where atmospher...many students see soil as "just dirt" a place to ...ors are challenged with the task of helping studen...e of soil in the environment. , A collaborative...s at University of Nebraska-Lincoln, Oregon State ...
(Date:11/24/2009)...ay named 12 new grant recipients for 2009. The awa...ork across a broad spectrum of lupus research. All...potential to drive scientific discovery to ultimat...f systemic lupus. , The 2009 grants go to both n...tion and include interdisciplinary and highly prom...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Catching a killer one spore at a time 10417 1Catching a killer one spore at a time 10417 2Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 59756 1Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 59756 2Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 59756 3Scientists Find New Key to Lupus 59752 1Scientists Find New Key to Lupus 59752 2
...years of growth before a tree is ready to flower -... scientists at universities in Sweden and the Unit...le for initiation of flowering. , In the annual pl...e sequenced, the genes Constans (CO) and Flowering...length. It turns out that Populus trees (aspens, c...
...nts, most people prefer to wipe the venomous littl...out of their own back yards. The reviled South Ame...40s Mobile, Ala., is known in biology circles as S... pest in the grass, so to speak. , Then there,s Wa...ne of its foremost researchers for more than 30 ye...
...a lawnmower, the Holy Grail of horticultural accom...lways green. , Now, that vision of suburban bliss... mapped a critical hormone signaling pathway that ...wns that rarely require mowing, the finding could ...tful crop plants such as rice, wheat, soybeans, an...
Other Biology News:Scientists discover that ancient genes dictate flowering, fall bud set 2Fire ants: Their true story told by the scientist who loves them 2Fire ants: Their true story told by the scientist who loves them 3No-mow grass may be coming to your yard soon 2No-mow grass may be coming to your yard soon 3
Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Goat Anti-FbxL7 Polyclonal Antibody, Unconjugated from GeneTex
Rabbit Anti-SERHL Polyclonal Antibody, Unconjugated from Abcam
Biology Products: